Free Trial
NASDAQ:AFIB

Acutus Medical (AFIB) Stock Price, News & Analysis

$0.03
0.00 (0.00%)
(As of 07/26/2024 ET)
Today's Range
$0.03
$0.04
50-Day Range
$0.03
$0.06
52-Week Range
$0.03
$0.79
Volume
5,090 shs
Average Volume
1.23 million shs
Market Capitalization
$906,460.00
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
AFIB stock logo

About Acutus Medical Stock (NASDAQ:AFIB)

Acutus Medical, Inc. designs, manufactures, and markets various tools for catheter-based ablation procedures to treat various arrhythmias in the United States and internationally. Its product portfolio includes novel access sheaths, transseptal crossing tools, diagnostic and mapping catheters, conventional and contact ablation catheters, and mapping and imaging consoles and accessories, as well as supporting algorithms and software programs. Acutus Medical, Inc. was incorporated in 2011 and is headquartered in Carlsbad, California.

AFIB Stock Price History

AFIB Stock News Headlines

625,000% Gain
Imagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetched, but results like this are within reach with the right knowledge and timing in the altcoin market. Plus, you’ll get $10 in real Bitcoin when you stay to the end of the call and take a short quiz.
Automatic Income (from home)
Everyone’s talking about this new income hack that could generate triple digit returns on your money. But here’s the best part…
AI Might Boost Detection of A-Fib
See More Headlines
Receive AFIB Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Acutus Medical and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
5/09/2024
Today
7/26/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Surgical & medical instruments
Sub-Industry
Medical Equipment
Current Symbol
NASDAQ:AFIB
Employees
340
Year Founded
2011

Profitability

Net Income
$-81,660,000.00
Pretax Margin
-100.90%

Debt

Sales & Book Value

Annual Sales
$7.16 million
Book Value
($0.03) per share

Miscellaneous

Free Float
28,173,000
Market Cap
$894,572.00
Optionable
Optionable
Beta
0.01

Social Links

The 10 Best AI Stocks to Own in 2024 Cover

Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

Get This Free Report

Key Executives

  • Mr. Takeo Mukai (Age 43)
    CEO & CFO
    Comp: $385.01k
  • Mr. Gary W. Doherty B.S. (Age 57)
    Senior Vice President of Finance
    Comp: $434.32k

AFIB Stock Analysis - Frequently Asked Questions

How have AFIB shares performed this year?

Acutus Medical's stock was trading at $0.2019 at the beginning of 2024. Since then, AFIB stock has decreased by 84.9% and is now trading at $0.0305.
View the best growth stocks for 2024 here
.

How were Acutus Medical's earnings last quarter?

Acutus Medical, Inc. (NASDAQ:AFIB) posted its earnings results on Thursday, May, 9th. The company reported ($0.07) EPS for the quarter. The business earned $3.63 million during the quarter.

Does Acutus Medical have any subsidiaries?

Acutus Medical subsidiaries include Acutus Medical N.V..

When did Acutus Medical IPO?

Acutus Medical (AFIB) raised $126 million in an initial public offering on Thursday, August 6th 2020. The company issued 7,400,000 shares at $16.00-$18.00 per share. J.P. Morgan, BofA Securities and William Blair acted as the underwriters for the IPO and Canaccord Genuity and BTIG were co-managers.

How do I buy shares of Acutus Medical?

Shares of AFIB stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

What other stocks do shareholders of Acutus Medical own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Acutus Medical investors own include Oak Street Health (OSH), Alibaba Group (BABA), Checkmate Pharmaceuticals (CMPI), Salesforce (CRM), Walt Disney (DIS), DocuSign (DOCU) and Marvell Technology (MRVL).

This page (NASDAQ:AFIB) was last updated on 7/26/2024 by MarketBeat.com Staff

From Our Partners